Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skul… Read more
Zimmer Biomet Holdings Inc (ZBH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.033x
Based on the latest financial reports, Zimmer Biomet Holdings Inc (ZBH) has a cash flow conversion efficiency ratio of 0.033x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($418.70 Million) by net assets ($12.77 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zimmer Biomet Holdings Inc - Cash Flow Conversion Efficiency Trend (1999–2024)
This chart illustrates how Zimmer Biomet Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zimmer Biomet Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zimmer Biomet Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chow Tai Fook Jewellery Group
PINK:CJEWY
|
-0.113x |
|
Tenet Healthcare Corporation
NYSE:THC
|
0.081x |
|
BWX Technologies Inc
NYSE:BWXT
|
0.115x |
|
Imperial Oil Ltd
NYSE MKT:IMO
|
0.113x |
|
Carnival Corporation & plc
PINK:CUKPF
|
0.124x |
|
Nidec Corporation
PINK:NNDNF
|
5.802x |
|
PTC Inc
NASDAQ:PTC
|
0.070x |
|
LyondellBasell Industries NV
NYSE:LYB
|
0.092x |
Annual Cash Flow Conversion Efficiency for Zimmer Biomet Holdings Inc (1999–2024)
The table below shows the annual cash flow conversion efficiency of Zimmer Biomet Holdings Inc from 1999 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $12.48 Billion | $1.50 Billion | 0.120x | -5.11% |
| 2023-12-31 | $12.49 Billion | $1.58 Billion | 0.127x | +18.56% |
| 2022-12-31 | $12.03 Billion | $1.28 Billion | 0.107x | -9.75% |
| 2021-12-31 | $12.67 Billion | $1.50 Billion | 0.118x | +19.88% |
| 2020-12-31 | $12.20 Billion | $1.20 Billion | 0.099x | -22.84% |
| 2019-12-31 | $12.39 Billion | $1.59 Billion | 0.128x | -17.43% |
| 2018-12-31 | $11.28 Billion | $1.75 Billion | 0.155x | +14.93% |
| 2017-12-31 | $11.74 Billion | $1.58 Billion | 0.135x | -20.12% |
| 2016-12-31 | $9.67 Billion | $1.63 Billion | 0.169x | +94.92% |
| 2015-12-31 | $9.81 Billion | $849.80 Million | 0.087x | -46.74% |
| 2014-12-31 | $6.52 Billion | $1.06 Billion | 0.163x | +6.36% |
| 2013-12-31 | $6.30 Billion | $963.10 Million | 0.153x | -22.15% |
| 2012-12-31 | $5.87 Billion | $1.15 Billion | 0.196x | -7.99% |
| 2011-12-31 | $5.51 Billion | $1.18 Billion | 0.213x | +3.20% |
| 2010-12-31 | $5.77 Billion | $1.19 Billion | 0.207x | +4.35% |
| 2009-12-31 | $5.64 Billion | $1.12 Billion | 0.198x | +7.94% |
| 2008-12-31 | $5.65 Billion | $1.04 Billion | 0.184x | -7.68% |
| 2007-12-31 | $5.45 Billion | $1.08 Billion | 0.199x | -5.91% |
| 2006-12-31 | $4.92 Billion | $1.04 Billion | 0.211x | +12.77% |
| 2005-12-31 | $4.69 Billion | $878.20 Million | 0.187x | -14.13% |
| 2004-12-31 | $3.95 Billion | $862.20 Million | 0.218x | +38.99% |
| 2003-12-31 | $3.15 Billion | $494.80 Million | 0.157x | -73.87% |
| 2002-12-31 | $366.30 Million | $220.20 Million | 0.601x | -72.46% |
| 2001-12-31 | $78.70 Million | $171.80 Million | 2.183x | +145.16% |
| 2000-12-31 | $261.00 Million | $232.40 Million | 0.890x | +93.42% |
| 1999-12-31 | $391.00 Million | $180.00 Million | 0.460x | -- |